Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Traditional Chinese Medicine may help treat hair loss but needs more research.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

Jamogenin and other molecules from plants may help treat hair loss.

Jamogenin and other compounds may help treat hair loss by inhibiting 5-alpha reductase.

Jamogenin and other molecules from plants may help treat hair loss.

Jamogenin and other molecules may help treat hair loss by inhibiting 5-alpha reductase.

Some plant-based products might treat hair loss with fewer side effects than current medications.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Finasteride can cause lasting sexual and mood issues even after stopping the drug.

Finasteride temporarily suppresses brain activity, but some effects last even after stopping.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.